The Everolimus-Transplant Exit Strategy Trial (E-TEST)

This study is currently recruiting participants.
Verified December 2013 by Emory University
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Allan D Kirk, MD, PhD, Emory University
ClinicalTrials.gov Identifier:
NCT01636466
First received: July 5, 2012
Last updated: December 2, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)